CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system

Cytotherapy
R K ZhongE D Ball

Abstract

Cells from AML patients can differentiate into the phenotype of DC when cultured with GM-CSF and IL-4. Such cytokine-treated AML-derived DC (AML-DC) can stimulate autologous T cells. In this study we examined whether an anti-CTLA-4 MAb (MDX-010) could enhance the generation of autologous anti-AML T cells. MAb MDX-010 was added to AML PBMC cultures in the presence of GM-CSF and IL-4, a previously reported AML-DC culture method of generating anti-AML T cells. T-cell activation and proliferation were examined thereafter. Addition of MDX-010 to GM-CSF/IL-4-conditioned AML-DC cultures induced a mean seven-fold increase in the numbers of autologous T cells compared with cultures without MDX-010 (P < 0.007). T cells stimulated by AML-DC with CTLA-4 blockade were significantly more cytotoxic towards autologous AML cells than those without MDX-010 (42 +/- 23% vs. 26 +/- 15%, E:T ratio of 20). T cells stimulated by AML-DC with CTLA-4 blockade had significantly greater proportions of T cells producing IFN-gamma in response to autologous AML cells than those cultured with AML-DC alone (10.7 +/- 4.7% vs. 4.5 +/- 2.4% for CD4+ IFN-gamma+ CD69+ and 9.8 +/- 4.1% vs. 4 +/- 2.1% for CD8+ IFN-gamma+ CD69+ with or without MDX-010; n = 7; P < 0.007...Continue Reading

References

Sep 1, 1991·The Journal of Experimental Medicine·P S LinsleyJ A Ledbetter
Aug 1, 1995·The Journal of Experimental Medicine·M F Krummel, J P Allison
Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Jun 1, 1996·The Journal of Experimental Medicine·M F Krummel, J P Allison
Jun 1, 1996·The Journal of Experimental Medicine·T L WalunasJ A Bluestone
Jan 1, 1996·Annual Review of Immunology·D J LenschowJ A Bluestone
Jun 1, 1997·Immunological Reviews·J H FalkenburgR Willemze
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·E M SotomayorH I Levitsky
Mar 22, 2002·Nature Reviews. Immunology·M L AlegreC B Thompson
Nov 19, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Rui-Kun ZhongEdward D Ball
Jan 25, 2003·British Journal of Haematology·Françoise VuillierDaniel Scott-Algara
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·F Stephen HodiGlenn Dranoff
Mar 24, 2004·Seminars in Immunology·Clare Baecher-AllanDavid A Hafler
Jun 21, 2005·Biochemical and Biophysical Research Communications·Barbara-Ann GuinnKen I Mills

❮ Previous
Next ❯

Citations

Dec 20, 2013·Journal for Immunotherapy of Cancer·Ryan M Teague, Justin Kline
Dec 22, 2012·Immunotherapy·Felix S LichteneggerMarion Subklewe
Nov 21, 2007·Cancer Investigation·Lee D Cranmer, Evan Hersh
Mar 21, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Theresia M WestersArjan A van de Loosdrecht
Dec 2, 2006·Leukemia Research·Dick Y Suh, Arthur E Frankel
Apr 22, 2006·Cytotherapy·A J Barrett, J Wolchok
Oct 25, 2016·The Journal of Clinical Investigation·Bethany L Mundy-BosseMichael A Caligiuri
Feb 3, 2016·Therapeutic Advances in Hematology·Kazusa Ishii, Austin J Barrett
Mar 16, 2018·Future Oncology·Amanda PrzespolewskiEunice S Wang
Jan 11, 2018·British Journal of Haematology·Willemijn HoboHarry Dolstra
Aug 5, 2015·Pharmacological Reviews·Sébastien AnguilleZwi N Berneman
Nov 30, 2019·British Journal of Haematology·A John Barrett
Jun 27, 2019·Cancers·Liam J O'BrienKristen J Radford
Jun 29, 2018·Frontiers in Oncology·Adam J Lamble, Evan F Lind
May 22, 2020·Frontiers in Oncology·Sherly Mardiana, Saar Gill
Dec 4, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chindu GovindarajMagdalena Plebanski
Oct 18, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ivana Gojo, Judith E Karp
Jun 16, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ofrat Beyar-Katz, Saar Gill
May 3, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amer M ZeidanB Douglas Smith
Dec 4, 2020·Critical Reviews in Oncology/hematology·Saeid Taghiloo, Hossein Asgarian-Omran
Jul 6, 2020·Critical Reviews in Oncology/hematology·Mohsen AlizadehBehzad Baradaran

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Cell Adhesion Molecules in the Brain

Cell adhesion molecules found on cell surface help cells bind with other cells or the extracellular matrix to maintain structure and function. Here is the latest research on their role in the brain.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.